Why Albireo Pharma Stock Is Skyrocketing Today

Why Albireo Pharma Stock Is Skyrocketing Today

Shares of Albireo Pharma (NASDAQ: ALBO) are up by 41.4% as of 11:49 a.m. EDT on Tuesday, after soaring by as much as 79% earlier today. The study investigated the safety and efficacy of odevixibat as a treatment for progressive familial intrahepatic cholestasis (PFIC). PFIC is a rare genetic disease; patients with this condition have difficulty draining bile, a digestive fluid in the liver.